Medical palliation of the jaundiced patient with pruritus

Gastroenterology Clinics of North America

Volumn 35, Issue 1, 2006, Pages 113-123

  Bergasa, Nora V ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; BUTORPHANOL; CODEINE; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; HYDROXYZINE; LIVER ENZYME; LORAZEPAM; METRONIDAZOLE; MIRTAZAPINE; NALMEFENE; NALOXONE; NALTREXONE; ONDANSETRON; OPIATE ANTAGONIST; OPIATE RECEPTOR; PAROXETINE; PHENOBARBITAL; RESIN; RIFAMPICIN; SEDATIVE AGENT; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNINDEXED DRUG;

AEROSOL; BLOATING; CHOLESTASIS; CLINICAL TRIAL; DRUG BINDING; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HUMAN; JAUNDICE; PALLIATIVE THERAPY; PARANEOPLASTIC SYNDROME; PLASMAPHERESIS; PRURITUS; REVIEW; SYMPTOM; UNSPECIFIED SIDE EFFECT;

CHOLESTASIS; HUMANS; JAUNDICE, OBSTRUCTIVE; PALLIATIVE CARE; PRURITUS;

EID: 33644827253     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2005.12.008     Document Type: Review

References (90)

1. J. Reichen, and F. Simon Cholestasis I.M. Arias W.B. Jakoby H. Popper The liver: biology and pathobiology 2nd edition 1988 Raven Press New York 1105 1124
2. S. Sherlock, and J. Dooley Cholestasis Diseases of the liver and biliary system 9th edition 1991 Blackwell London 214 235
3. R.I. Hall, M.E. Denyer, and A.H. Chapman Percutaneous-endoscopic placement of endoprostheses for relief of jaundice caused by inoperable bile duct strictures Surgery 107 2 1990 224 227
4. E. Feller, and F.J. Schiffman Extrahepatic biliary obstruction by lymphoma Arch Surg 125 11 1990 1507 1509
5. E. Elias Liver transplantation Clin Med 27 1993 224 232
6. H.G. Lloyd-Thomas, and S. Sherlock Testosterone therapy for the pruritus of obstructive jaundice BMJ 2 4797 1952 1289 1291
7. E.A. Jones, and N.V. Bergasa The pruritus of cholestasis: from bile acids to opiate agonists Hepatology 11 5 1990 884 887
8. J.R. Thornton, and M.S. Losowsky Opioid peptides and primary biliary cirrhosis BMJ 297 6662 1988 1501 1504
9. N.V. Bergasa, T.L. Talbot, and J.P. Schmitt Open label trial of oral nalmefene therapy for the pruritus of cholestasis Hepatology 27 1998 679 684
10. N.V. Bergasa, D.W. Alling, and J. Vergalla Cholestasis in the male rat is associated with naloxone-reversible antinociception J Hepatol 20 1994 85 90
11. N.V. Bergasa, R.B. Rothman, and J. Vergalla Down-regulation of delta opioid receptors in bile duct resected rats: further evidence for alteration in the opioid system in cholestasis Gastroenterology 102 1992 A946
12. S. Inan, and A. Cowan Reduced kappa-opioid activity in a rat model of cholestasis Eur J Pharmacol 518 2-3 2005 182 186
13. M.C. Ko, M.S. Song, and T. Edwards The role of central mu opioid receptors in opioid-induced itch in primates J Pharmacol Exp Ther 310 1 2004 169 176
14. J.C. Ballantyne, A.B. Loach, and D.B. Carr Itching after epidural and spinal opiates Pain 33 2 1988 149 160
15. T.K. Abbound, K. Lee, and J. Zhu Prophylactic oral naltrexone with intrathecal morphine for cesarean section: effects on adverse reactions and analgesia Anesth Analg 71 4 1990 367 370
16. J.R. Thornton, and M.S. Losowsky Plasma methionine enkephalin concentration and prognosis in primary biliary cirrhosis BMJ 297 1988 1241 1242
17. N.V. Bergasa, S.L. Sabol, and W.S.D. Young Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver Am J Physiol 268 2 Pt 1 1995 G346 G354
18. N.V. Bergasa, J. Vergalla, and M.G. Swain Hepatic concentration of proenkephalin-derived opioids are increased in a rat model of cholestasis Liver 16 1996 298 302
19. N. Bergasa Hepatic met-enkephalin immunoreactivity is enhanced in primary biliary cirrhosis Liver 22 2 2002 107 113
20. C.G. Dietrich, A. Geier, and R.P. Oude Elferink ABC of oral bioavailability: transporters as gatekeepers in the gut Gut 52 12 2003 1788 1795
21. S.M. Dombrowski, S.Y. Desai, and M. Marroni Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy Epilepsia 42 12 2001 1501 1506
22. K.A. Hoffmaster, M.J. Zamek-Gliszczynski, and G.M. Pollack Hepatobiliary disposition of the metabolically stable opioid peptide [d-Pen2, d-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems J Pharmacol Exp Ther 311 3 2004 1203 1210
23. K.A. Hoffmaster, M.J. Zamek-Gliszczynski, and G.M. Pollack Multiple transport systems mediate the hepatic uptake and biliary excretion of the metabolically stable opioid peptide [d-penicillamine2, 5]enkephalin Drug Metab Dispos 33 2 2005 287 293
24. W.A. Banks, and A.J. Kastin Peptide transport systems for opiates across the blood-brain barrier Am J Physiol 259 1 Pt 1 1990 E1 E10
25. W.A. Banks, and A.J. Kastin Saturable transport of peptides across the blood-brain barrier Life Sci 41 11 1987 1319 1338
26. I.S. Zagon, P.J. McLaughlin, and S.R. Goodman Opioid receptors and endogenous opioids in diverse human and animal cancers J Natl Cancer Inst 79 5 1987 1059 1065
27. E. Caretta Three cases of paraneoplastic syndrome caused by lymphoma of the small intestine Minerva Med 72 43 1981 2905 2912
28. A. Karakolios, C. Kasapis, and T. Kallinikidis Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma Clin Gastroenterol Hepatol 1 6 2003 480 483
29. V.C. Adreev, and I. Petkov Skin manifestations associated with tumours of the brain Br J Dermatol 92 6 1975 675 678
30. T.L. Talbot, J.M. Schmitt, and N.V. Bergasa Application of piezo film technology for the quantitative assessment of pruritus Biomed Instrum Technol 25 5 1991 400 403
31. H. Stein, M. Bijak, and E. Heerd [Pruritometer 1: portable measuring system for quantifying scratching as an objective measure of cholestatic pruritus] Biomed Tech (Berl) 41 9 1996 248 252 [in German]
32. H.A. Molenaar, J. Oosting, and E.A. Jones Improved device for measuring scratching activity in patients with pruritus Med Biol Eng Comput 36 2 1998 220 224
33. M. Bijak, W. Mayr, and D. Rafolt [Pruritometer 2: portable recording system for the quantification of scratching as objective criterion for the pruritus] Biomed Tech (Berl) 46 5 2001 137 141 [in German]
34. Z. Zylicz, N. Stork, and M. Krajnik Severe pruritus of cholestasis in disseminated cancer: developing a rational treatment strategy: a case report J Pain Symptom Manage 29 1 2005 100 103
35. M. Raderer, C. Muller, and W. Scheithauer Ondansetron for pruritus due to cholestasis N Engl J Med 21 1994 1540
36. Z. Zylicz, C. Smits, and M. Krajnik Paroxetine for pruritus in advanced cancer J Pain Symptom Manage 16 2 1998 121 124
37. M.P. Davis, J.L. Frandsen, and D. Walsh Mirtazapine for pruritus J Pain Symptom Manage 25 3 2003 288 291
38. W. Douglas The pharmacological basis of therapeutics 7th edition 1975 Macmillan Publishing Company New York
39. Z. Zylicz, M. Krajnik, and A.A. Sorge Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial J Pain Symptom Manage 26 6 2003 1105 1112
40. J.D. Browning, B. Combes, and M. Mayo Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhois Am J Gastroenterol 98 12 2003 2736 2741
41. M. Mayo Effect of sertraline on pruritus in cholestatic liver disease: a randomized double blind placebo controlled crossover study Hepatology 4 Suppl 1 2005 S60
42. S. Kasper Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data Int Clin Psychopharmacol Suppl 4 1995 S25 S35
43. H. Schworer, H. Hartmann, and G. Ramadori Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron Pain 61 1 1995 33 37
44. J.W. O'Donohue, S.P. Pereira, and A.C. Ashdown A controlled trial of ondansetron in the pruritus of cholestasis Aliment Pharmacol Ther 21 8 2005 1041 1045
45. N.V. Bergasa, D.W. Alling, and T.L. Talbot Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study J Am Acad Dermatol 41 3 1999 431 434
46. N.V. Bergasa, T.L. Talbot, and D.W. Alling A controlled trial of naloxone infusions for the pruritus of chronic cholestasis Gastroenterology 102 2 1992 544 549
47. N.V. Bergasa, D.W. Alling, and T.L. Talbot Naloxone ameliorates the pruritus of cholestasis: results of a double-blind randomized placebo-controlled trial Ann Intern Med 123 3 1995 161 167
48. F.H.J. Wolfhagen, E. Sternieri, and W.C.J. Hop Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study Gastroenterology 113 4 1997 1264 1269
49. K.L. Carson, T.T. Tran, and P. Cotton Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease Am J Gastroenterol 91 1996 1022 1023
50. R. Terg, E. Coronel, and J. Sorda Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis: a crossover, double blind, placebo-controlled study J Hepatol 37 6 2002 717 722
51. E.A. Jones, and N.V. Bergasa The pathogenesis and treatment of pruritus and fatigue in patients with PBC Eur J Gastroenterol Hepatol 11 6 1999 623 631
52. E.A. Jones, J. Neuberger, and N.V. Bergasa Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions QJM 95 8 2002 547 552
53. L.D. Juby, V.S. Wong, and M.S. Losowsky Buprenorphine and hepatic pruritus British Journal of Clinical Practice 48 6 1994 331
54. K. Fukuda, S. Kato, and K. Mori Location of regions of the opioid receptor involved in selective agonist binding J Biol Chem 270 12 1995 6702 6709
55. C. Mignat, U. Wille, and A. Ziegler Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes Life Sci 56 10 1995 793 799
56. L. Yu The mu opioid receptor: from molecular cloning to functional studies Addict Biol 1 1 1996 19 30
57. H. Umeuchi, Y. Togashi, and T. Honda Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system Eur J Pharmacol 477 1 2003 29 35
58. M.C. Ko, H. Lee, and M.S. Song Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys J Pharmacol Exp Ther 305 1 2003 173 179
59. M.C. Ko, and N.N. Naughton An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception Anesthesiology 92 3 2000 795 805
60. D.V. Datta, and S. Sherlock Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis Gastroenterology 50 1966 323 332
61. C. Berg Use of colesevelam hydrochloride (Welchol) as a novel therapeutic agent for the management of refractory pruritus in chronic liver disease Hepatology 34 2001 541
62. E.P. Ambinder, L.B. Cohen, and A.M. Wolke The clinical effectiveness and safety of chronic plasmapheresis in patients with primary biliary cirrhosis J Clin Apheresis 2 3 1985 219 223
63. L.B. Cohen, E.P. Ambinder, and A.M. Wolke Role of plasmapheresis in primary biliary cirrhosis Gut 26 3 1985 291 294
64. M. Joannidis, R. Bellmann, and I. Graziadei Current indications for the albumin dialysis: intractable pruritus Proceedings of the 4th International Symposium on Albumin Dialysis in Liver Disease 2002 Rostock-Warnemünde 27
65. J. Strange, T.L. Hassanein, and R. Mehta The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers Artif Organs 26 2002 103 110
66. E. Sturm, C.F. Franssen, and A. Gouw Extracorporeal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC) Liver 22 Suppl 2 2002 S72 S75
67. P. Whitington, and G. Whitington Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis Gastroenterology 95 1988 130 136
68. K.M. Emerick, and P.F. Whitington Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome Hepatology 35 6 2002 1501 1506
69. C.M. Hollands, F.J. Rivera-Pedrogo, and R. Gonzalez-Vallina Ileal exclusion for Byler's disease: an alternative surgical approach with promising early results for pruritus J Pediatr Surg 33 2 1998 220 224
70. J.R. Bloomer, and J.L. Boyer Phenobarbital effects in cholestatic liver diseases Ann Intern Med 82 3 1975 310 317
71. C.N. Ghent, J.R. Bloomer, and Y.E. Hsia Efficacy and safety of long-term phenobarbital therapy of familial cholestasis J Pediatr 93 1 1978 127 132
72. L. Bachs, A. Parés, and M. Elena Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis Lancet 1 8638 1989 574 576
73. L. Bachs, A. Parés, and M. Elena Effects of long-term rifampicin administration in primary biliary cirrhosis Gastroenterology 102 6 1992 2077 2080
74. C.N. Ghent, and S.G. Carruthers Treatment of pruritus in primary biliary cirrhosis with rifampin: results of a double-blind, crossover, randomized trial Gastroenterology 94 2 1988 488 493
75. R.G. Tirona, B.F. Leake, and A.W. Wolkoff Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation J Pharmacol Exp Ther 304 1 2003 223 228
76. M.J. Kreek, J.W. Garfield, and C.L. Gutjahr Rifampin-induced methadone withdrawal N Engl J Med 294 20 1976 1104 1106
77. M.I. Prince, A.D. Burt, and D.E. Jones Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis Gut 50 3 2002 436 439
78. C. Berg, and J. Gollan Primary biliary cirrhosis Scand J Gastroenterol 192 Suppl 1992 S43 S49
79. A. Borgeat, O.H.G. Wilder-Smith, and G. Mentha Subhypnotic doses of propofol relieve pruritus associated with liver disease Gastroenterology 104 1993 244 247
80. A. Borgeat, O. Wilder-Smith, and M. Saiah Subhypnotic doses of propofol relieve pruritus induced by epidural and intrathecal morphine Anesthesiology 76 1992 510 512
81. W.C. Watson Intravenous lignocaine for relief of intractable itch Lancet 1 7796 1973 211
82. A.G. Villamil, J.C. Bandi, and O.A. Galdame Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases Am J Med 118 10 2005 1160 1163
83. P. Joffe, L.W. Andersen, and J. Molvig Intravenous lidocaine in the treatment of pruritus in hemodialysis patients Clin Nephrol 24 4 1985 214
84. S.M. Fishman, O.A. Caneris, and M.P. Stojanovic Intravenous lidocaine for treatment-resistant pruritus Am J Med 102 6 1997 584 585
85. I.D. Meng, B.H. Manning, and W.J. Marting An analgesia circuit activated by cannabinoids Nature 395 1998 381 383
86. J.A. Fuentes, M. Ruiz-Gayo, and J. Manzanares Cannabinoids as potential new analgesics Life Sci 65 6-7 1999 675 685
87. G.W. Neff, C.B. O'Brien, and A. Regev The remedy for intractable cholestatic related pruritus: delta-9-tetrahydrocannabinol (Marinol) [abstract] Hepatology 30 1999 328
88. G.W. Neff, C.B. O'Brien, and K.R. Reddy Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease Am J Gastroenterol 97 8 2002 2117 2119
89. M. Backonja, and R.L. Glanzman Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials Clin Ther 25 1 2003 81 104
90. H.A. Bueller, J.D. Bernhard, and L.M. Dubroff Gabapentin treatment for brachioradial pruritus J Eur Acad Dermatol Venereol 13 3 1999 227 228